{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:37:31Z","timestamp":1791171451924,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background:<\/jats:title><jats:p>It has been suggested that an exaggerated immune response to fungi is crucial in the pathogenesis of chronic rhinosinusitis (CRS). Based on this rationale, the use of topical antifungals (amphotericin B) has been advocated. Studies on its clinical effectiveness are, however, contradictory.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives:<\/jats:title><jats:p>To examine the effect of nasal antifungal treatment on secreted mediators in samples of nasal lavage fluid from patients with CRS with or without nasal polyps (NP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Part two of a prospective double\u2010blind, placebo\u2010controlled multicenter clinical trial investigating the effect of 13 weeks of treatment with amphotericin B or placebo on the levels of pro\u2010inflammatory cytokines, chemokines and growth factors (i.e., IL\u20101\u03b2, IL\u20101RA, IL\u20102, IL\u20102R, IL\u20103, IL\u20104, IL\u20105, IL\u20106, IL\u20107, IL\u20108, IL\u201010, IL\u201012 (p40\/p70 subunits), IL\u201013, IL\u201015, IL\u201017, TNF\u2010\u03b1, IFN\u2010\u03b1, IFN\u2010\u03b3, G\u2010CSF, GM\u2010CSF, MIP\u20101\u03b1, MIP\u20101\u03b2, IP\u201010, MIG, eotaxin, RANTES, MCP\u20101, MCP\u20102, MCP\u20103, VEGF, EGF, FGF\u2010basic, HGF, Gro\u2010\u03b1) and albumin via a fluorescent enzyme immunoassay in nasal lavage specimens of CRS patients with or without NP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Topical amphotericin B had no significant effect on the level of any of the tested pro\u2010inflammatory cytokines, chemokines, and growth factors in CRS nasal lavage samples. Treatment with placebo, however, increased the level of MIP\u20101\u03b1 and MIP\u20101\u03b2, which are mediators involved in wound healing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Topical amphotericin B has no significant effect on activation markers of nasal inflammatory cells in chronic rhinosinusitis with or without nasal polyps. Laryngoscope, 2009<\/jats:p><\/jats:sec>","DOI":"10.1002\/lary.20064","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T18:14:44Z","timestamp":1232561684000},"page":"401-408","source":"Crossref","is-referenced-by-count":69,"title":["The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: A multicenter randomized controlled study"],"prefix":"10.1002","volume":"119","author":[{"given":"Fenna A.","family":"Ebbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Georgalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis M.","family":"van Drunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Badia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenis K.","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jorissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Mullol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda","family":"Cardesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut P. J.","family":"van Zele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie J.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J.","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2007","volume":"45","author":"Fokkens WJ","year":"2007","journal-title":"Rhinology"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.4065\/74.9.877"},{"key":"e_1_2_5_4_2","first-page":"178","article-title":"The fungal debate: where do we stand today?","volume":"45","author":"Ebbens FA","year":"2007","journal-title":"Rhinology"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-008-0018-6"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.09.037"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.130051"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1258\/0022215021910708"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.03.038"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.07.058"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01323.x"},{"key":"e_1_2_5_12_2","first-page":"259","article-title":"Macrolide therapy of chronic rhinosinusitis","volume":"45","author":"Cervin A","year":"2007","journal-title":"Rhinology"},{"key":"e_1_2_5_13_2","first-page":"183","article-title":"Staging in rhinosinusitus","volume":"31","author":"Lund VJ","year":"1993","journal-title":"Rhinology"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1998.tb00344.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1399-0012.1997.tb01052.x","article-title":"Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient","volume":"11","author":"Kfoury AG","year":"1997","journal-title":"Clin Transplant"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.5.1152"},{"key":"e_1_2_5_17_2","first-page":"201","article-title":"Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B","volume":"41","author":"Jornot L","year":"2003","journal-title":"Rhinology"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20347"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016480410017404"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.132.7.743"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/08958370390197290","article-title":"Nasal lavage method in the monitoring of upper airway inflammation: seasonal and individual variation","volume":"15","author":"Roponen M","year":"2003","journal-title":"Inhal Toxicol"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199902000-00012"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(02)00045-X"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.5.2677"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/76957"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.11.6429"},{"key":"e_1_2_5_27_2","first-page":"29","article-title":"Nasal douching as a valuable adjunct in the management of chronic rhinosinusitis","volume":"37","author":"Taccariello M","year":"1999","journal-title":"Rhinology"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004050000271"},{"key":"e_1_2_5_29_2","first-page":"1049","article-title":"Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial","volume":"51","author":"Rabago D","year":"2002","journal-title":"J Fam Pract"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flary.20064","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.20064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T03:04:20Z","timestamp":1738897460000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lary.20064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1002\/lary.20064"],"URL":"https:\/\/doi.org\/10.1002\/lary.20064","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}